MedTrace Logo

The Nanowear Wearable Covid-19 Observational and Analysis Trend

NCT04717024 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2026-04-09

No results posted yet for this study

Summary

The NanoCOAT study is a multi-center, prospective, non-randomized, feasibility, observational, non-significant risk study. The NanoCOAT study will enroll a minimum of 10 and a maximum of 100 subjects in a potential for a multi-site in order to collect data and analyze physiological and biometric trends due to Covid-19.

Conditions

  • Covid19

Interventions

DEVICE

Observational Study - no intervention

Observational Study - no intervention

Sponsors & Collaborators

  • Nanowear Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-15
Primary Completion
2021-04-15
Completion
2021-04-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04717024 on ClinicalTrials.gov